The following information appeared on, ama.assn.org
The Current Procedural Terminology (CPT®) Editorial Panel (the Panel) has approved a new vaccine administration code (0083A) for the third dose of the Pfizer vaccine product to address severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease 2019 [COVID-19]) in pediatric patents aged 6 months through 4 years. This code will become effective upon receiving the emergency use authori-zation (EUA) from the Food and Drug Administration (FDA). The special edition of the AMA CPT Assistant has an excellent overview of the billing guidelines for the new pediatric vaccines.
